Co-Authors
This is a "connection" page, showing publications co-authored by Benjamin Shogan and Konstantin Umanskiy.
Connection Strength
1.508
-
Do we really know why colorectal anastomoses leak? J Gastrointest Surg. 2013 Sep; 17(9):1698-707.
Score: 0.469
-
Caring for Patients with Rectal Cancer During the COVID-19 Pandemic. J Gastrointest Surg. 2020 07; 24(7):1698-1703.
Score: 0.190
-
Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis. Dis Colon Rectum. 2019 11; 62(11):1344-1351.
Score: 0.183
-
Collagen degradation and MMP9 activation by Enterococcus faecalis contribute to intestinal anastomotic leak. Sci Transl Med. 2015 May 06; 7(286):286ra68.
Score: 0.134
-
Proceedings of the first international summit on intestinal anastomotic leak, Chicago, Illinois, October 4-5, 2012. Surg Infect (Larchmt). 2014 Oct; 15(5):479-89.
Score: 0.128
-
Simple Diverting Colostomy for Sacral Pressure Ulcers: Not So Simple After All. J Gastrointest Surg. 2023 02; 27(2):382-389.
Score: 0.057
-
Histopathology of Colectomy Specimens Predicts Endoscopic Pouch Phenotype in Patients with Ulcerative Colitis. Dig Dis Sci. 2022 08; 67(8):4020-4031.
Score: 0.054
-
Neoadjuvant Therapy for cT2N0M0 Rectal Cancer? J Gastrointest Surg. 2022 02; 26(2):479-482.
Score: 0.052
-
The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn's Disease. Digestion. 2021; 102(5):767-775.
Score: 0.050
-
Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes. Clin Gastroenterol Hepatol. 2022 02; 20(2):293-302.e9.
Score: 0.050
-
Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications. Crohns Colitis 360. 2020 Jul; 2(3):otaa064.
Score: 0.048
-
Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2020 06; 51(12):1365-1372.
Score: 0.047
-
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095.
Score: 0.045